BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Prognosis
54 results:

  • 1. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
    Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
    ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association Between a History of breast cancer and Decreased Thyroid cancer-specific Mortality.
    Lin S; Wang Z; Xing M
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Audit of Sex and Gender Medicine Topics in Preclinical School of Medicine Curriculum.
    Trieglaff K; Zamzow MJ; Sutherland B; Farkas A; Pfister S
    WMJ; 2023 Sep; 122(4):243-249. PubMed ID: 37768763
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients.
    Tawfiq E; Pylypchuk R; Elwood JM; McKeage M; Wells S; Selak V
    Cancer Med; 2023 Oct; 12(19):20081-20093. PubMed ID: 37746882
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
    Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
    J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.
    Kim MH; Kim GM; Ahn JM; Ryu WJ; Kim SG; Kim JH; Kim TY; Han HJ; Kim JY; Park HS; Park S; Park BW; Kim SI; Jeong J; Lee J; Paik S; Kim S; Jung KH; Cho EH; Sohn J
    J Natl Cancer Inst; 2023 Sep; 115(9):1036-1049. PubMed ID: 37166557
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.
    Wang L; Mi D; Hu J; Liu W; Zhang Y; Wang C; Chen Y; Chen C
    Cancer Lett; 2023 Feb; 555():216049. PubMed ID: 36608865
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of Long-term Oncologic prognosis With Minimal Access breast Surgery vs Conventional breast Surgery.
    Wan A; Liang Y; Chen L; Wang S; Shi Q; Yan W; Cao X; Zhong L; Fan L; Tang P; Zhang G; Xiong S; Wang C; Zeng Z; Wu X; Jiang J; Qi X; Zhang Y
    JAMA Surg; 2022 Dec; 157(12):e224711. PubMed ID: 36197680
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer.
    Wu Y; Han Y; Li Q; Zhang P; Yuan P; Luo Y; Fan Y; Chen S; Cai R; Li Q; Xu H; Wang Y; Ma F; Wang J; Xu B
    Breast Cancer Res Treat; 2022 Jun; 193(2):381-392. PubMed ID: 35297009
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The
    Song C; Kendi AT; Lowe VJ; Lee S
    Anticancer Res; 2022 Feb; 42(2):681-695. PubMed ID: 35093867
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.
    Silvestri M; Dugo M; Vismara M; De Cecco L; Lanzoni D; Vingiani A; Folli S; De Santis MC; de Braud F; Pruneri G; Di Cosimo S; Cappelletti V
    Sci Rep; 2022 Jan; 12(1):1470. PubMed ID: 35087134
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
    Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Low RAI2 expression is a marker of poor prognosis in breast cancer.
    Nishikawa S; Uemoto Y; Kim TS; Hisada T; Kondo N; Wanifuchi-Endo Y; Fujita T; Asano T; Katagiri Y; Terada M; Kato A; Dong Y; Sugiura H; Okuda K; Kato H; Osaga S; Takahashi S; Toyama T
    Breast Cancer Res Treat; 2021 May; 187(1):81-93. PubMed ID: 33782811
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CD10-Negative Primary breast Follicular Lymphoma: A Rare Case of Primary breast Lymphoma With an Atypical Immunophenotype Mimicking Marginal Zone Lymphoma.
    Miura S; Hashimoto H; Sawada T; Ishida T; Usuki K; Morikawa T
    Int J Surg Pathol; 2021 Jun; 29(4):400-403. PubMed ID: 33252276
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Development of a novel immune-related genes prognostic signature for osteosarcoma.
    Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
    Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
    Kurozumi S; Alsaleem M; Monteiro CJ; Bhardwaj K; Joosten SEP; Fujii T; Shirabe K; Green AR; Ellis IO; Rakha EA; Mongan NP; Heery DM; Zwart W; Oesterreich S; Johnston SJ
    Breast Cancer Res; 2020 Aug; 22(1):85. PubMed ID: 32782013
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer.
    Aagaard T; Reekie J; Jørgensen M; Roen A; Daugaard G; Specht L; Sengeløv H; Mocroft A; Lundgren J; Helleberg M
    Cancer Med; 2020 May; 9(9):3033-3042. PubMed ID: 32144897
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological Features, Treatment, and prognosis in Primary Diffuse Large B Cell Lymphoma of the breast: A Retrospective Study of 46 Patients.
    Luo H; Yi P; Wang W; Li K; Meng L; Li J; Zeng W; Tang M
    Med Sci Monit; 2019 Nov; 25():8671-8682. PubMed ID: 31734687
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
    Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
    Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association Between Pretreatment Serum Apolipoprotein A1 and prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
    Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
    Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.